RCT | In patients undergoing cardiac surgery, intravenous high-dose selenium did not reduce morbidity or mortality

Effect of High-Dose Selenium on Postoperative Organ Dysfunction and Mortality in Cardiac Surgery Patients: The SUSTAIN CSX Randomized Clinical Trial – JAMA Surgery

Commentary on Twitter

In this study, high-dose sodium selenite was not effective in reducing the development of organ dysfunction and death in high-risk cardiac surgery patients. @CStoppe @CriticalCa https://t.co/H3HR1u1HhU

— JAMA Surgery (@JAMASurgery) January 12, 2023